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ABSTRACT: A highly enantioselective (>95% ee) strategy to aﬀect
the desymmetrization of a maleimide has been performed by
temporary attachment to an anthracene template followed by
asymmetric reduction with an oxazaborolidine catalyst. A stereo-
ablative over-reduction process was partially responsible for the high
levels of enantioselectivity. Exempliﬁcation of the strategy by
stereoselective functionalization and retro-Diels−Alder reaction
provided the natural product pyrrolam A.
Desymmetrization of a meso-compound using a chiralreagent or catalyst provides a powerful and versatile
strategy in asymmetric synthesis as a single stereodiﬀerentiating
step can facilitate the formation of multiple stereogenic
centers.1 Cyclic meso-imides represent a useful class of such
compounds as stereoselective reduction of one of the carbonyl
groups leads to a product with three contiguous stereogenic
centers. Various strategies have been reported for the
desymmetrization of meso-imides to achieve chiral compounds
with high enantioselectivity,2 including reduction using oxaza-
borolidine catalysts.3 Work from this laboratory has shown that
an alternative catalyst derived from cis-1-aminoindan-2-ol is
much more eﬀective for this desymmetrization process and that
the protecting group on the nitrogen atom of the imide plays an
important role in moderating the yield and selectivity of the
transformations.4
Although reductive enantioselective desymmetrization of
meso-imides is a very eﬀective strategy, it is limited to 3,4-
disubstituted saturated imides. Direct desymmerization of
maleimides and succinimides by reduction cannot be
performed due to the Cs symmetry from the second mirror
plane in the molecule, coupled with the propensity of the newly
installed hydroxylactam stereogenic center to undergo inver-
sion, leading to racemization. A way to circumvent this is to
temporarily change the symmetry to C2v by a transformation
that removes the second mirror plane, for example, through a
Diels−Alder reaction with anthracene. Desymmetrization
followed by functionalization of the intermediate hydroxy-
lactam and removal by a retro-Diels−Alder reaction would
reveal the chiral α,β-unsaturated lactam (Scheme 1).
A secondary advantage of this method is that the
stereoselectivity of any subsequent functionalization step
should be enhanced due to the rigid bicyclic nature of the
intermediate before the ﬁnal retro-Diels−Alder reaction.5
Previous work from this group demonstrated that
desymmetrization of N-functionalized meso-imides derived
from cis-cyclohexane-1,2-dicarboxylic acid gives essentially one
enantiomer of product when N-phenyl groups are used.4b
However, only moderate yields were obtained with this
protecting group, in addition to it being problematic to
remove. For the substrates in this work, it was not clear which
protecting group would provide the better results since it could
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Scheme 1. Use of Anthracene Template for
Desymmerization of N-Substituted Maleimides
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be envisioned that the presence of the anthracene framework
would allow the use of the more useful N-benzyl protecting
group, as the conformation of this substrate would be eﬀectively
restricted compared to the those previously investigated. Thus,
the synthesis of N-benzyl imide cycloadduct 2 was achieved by
a Diels−Alder reaction between maleic anhydride and
anthracene to furnish the anhydride cycloadduct 1, which was
condensed with benzylamine to give the desired N-benzyl
imide cycloadduct 2 in 89% yield over two steps (Scheme 2).
The p-(methoxybenzyl) derivative was synthesized using the
same methodology employed for the N-benzyl derivative giving
the N-PMB imide 3 in 88% yield. In the case of the p-
(methoxyphenyl) derivative 5, an alternative route was adopted
ﬁrst involving formation of maleimide 4 in 67% yield, followed
by cycloaddition that proceeded in quantitative yield.
In previous work, BH3·THF was determined to be the
optimal borane source for the desymmetrization process as
there was no competing background reaction, with the optimal
catalyst loading being 10 mol %.4 The N-PMP cycloadduct 5
also showed only 2% conversion to the corresponding
hydroxylactam when treated with BH3·THF stirred at room
temperature for 18 h. With this information in hand, various
oxazaborolidine catalysts were tested using the N-PMP
derivative 5 as a benchmark substrate, using 10 mol % loading
and BH3·THF as the reducing agent. In every case, the
hydroxylactam formed was converted into the more stable
corresponding methoxyaminal by treatment with acid in
methanol (Scheme 3). The initial results showed the cis-1-
aminoindan-2-ol-based catalysts to be superior to the diphenyl
prolinol catalyst both in terms of yield and enantiomeric excess
(compare entries 1−3 with entry 4, Table 1), all giving
excellent enantiocontrol and a consistent yield of around 55%
over the two steps (Table 1). As observed in previous studies,
there was evidence from the 1H NMR spectra that the low yield
obtained is due to over-reduction of the pyrrolidine.4b
Upon further investigation, we found that this over-reduction
process is critical for obtaining products of high enantiomeric
excess. Scalemic hydroxylactam 13 (34% ee) was subjected to
both enantiomers of catalyst 10 under standard reaction
conditions (Scheme 4), leading to a stereoablative process that
upgraded the enantiomeric purity through selective over-
reduction of only one enantiomer of hydroxylactam.6 This
appears to be the ﬁrst example of such a transformation being
used in an oxazaborolidine-catalyzed reduction.
As all the three aminoindanol-based oxazaborolidines
demonstrated near identical yields and enantioselectivity, only
the B-OMe catalyst 10 was used in subsequent tests with the
other nitrogen protecting groups. With the N-benzyl derivative
2, the yield of the methoxylactam 7 was increased to 85%;
however, the enantioselectivity dropped slightly to 95% (Table
1, entry 5), following the previously reported trend with meso-
imides.4b With N-PMB derivative 3, the enantioselectivity of
the reaction was similar at 97%; however, the yield dropped to
a disappointing 21% (Table 1, entry 6). In this case, the low
yield is due to poor conversion (53% of starting material) in the
asymmetric reduction. In all cases, the relative stereochemistry
of the resulting products was conﬁrmed from the crystal
structures for methoxyaminals 6 and 7, clearly indicating that
the methanol had approached from the top face of the
intermediate N-acyl iminium ion. Correlation of the coupling
constants of these compounds with that of methoxyaminal 8
indicated that this was also likely to possess the same relative
Scheme 2. Preparation of N-Bn, N-PMB, and N-PMP
Cycloadducts
Scheme 3. Evaluation of Catalyst and Nitrogen Protecting
Group
Table 1. Evaluation of Catalyst and Nitrogen Protecting
Groupa
entry catalyst substrate/product yield (%)b ee (%)c
1 9 5/6 (R = PMP) 55 96
2 10 5/6 (R = PMP) 61 99
3 11 5/6 (R = PMP) 50 99
4 12 5/6 (R = PMP) 15 4
5 10 2/7 (R = Bn) 85 95
6 10 3/8 (R = PMB) 21 97
aReactions performed by addition of catalyst 9−11 (0.25 mmol) in
THF (1 mL) to a stirred solution of imide 2, 3, or 5 (2.5 mmol) in
THF (20 mL), followed by addition of BH3·THF (2.5 mL, 2.5 mmol)
at rt. Standard workup and conversion to the methoxylactam is
described in the Supporting Information. bRefers to isolated product.
cEnantiomeric excess determined by chiral stationary phase HPLC.
Scheme 4. Stereoablative Upgrade of Enantioselectivity
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conﬁguration. The absolute conﬁguration was conﬁrmed by
subsequent synthetic studies.
Functionalization of these products was demonstrated by
Lewis-acid-mediated displacement of the methoxy group of
aminal 6 and reaction of the N-acyl iminium ion formed with
allyltrimethyl silane.3a Thus, N-PMP O-methyl aminal 6 was
treated with allyl trimethylsilane in the presence of boron
triﬂuoride at −78 °C, providing the C-allyl lactam 14 in good
yield (74%) as a single diastereoisomer (Scheme 5).
Correlation of the coupling constants again provided evidence
that addition had occurred at the top of the intermediate N-acyl
iminium ion.
To illustrate the synthetic applicability, lactam 14 was used as
a substrate to prepare pyrrolam A. This natural product was
ﬁrst isolated by Grote et al. in 1990 from the bacterial strain
Streptomyces olivaceus (strain Tü 3082) along with three other
related compounds, pyrrolams B−D.7 Pyrrolam A was shown
to have only modest biological activity, with low herbicidal
activity and was inactive against both Gram-positive and Gram-
negative bacteria, fungi, molds, viruses, worms, protozoa, and
tumor cell lines. Since its isolation, there have been a number of
reported syntheses, many of which employ a chiral pool
approach.8
Deprotection of PMP-lactam 13 using CAN gave the lactam
15 in 84% yield (Scheme 6). Hydroboration of this by
treatment with BH3·THF followed by NaOH/H2O2 yielded the
alcohol 16. Although the 1H NMR spectrum of the crude
reaction material showed 100% conversion of the lactam 15, all
eﬀorts to purify compound 16 by both ﬂash chromatography
and recrystallization failed. Hence, the alcohol 16 was treated
with methanesulfonyl chloride and triethylamine to give the
mesylate 17 with complete conversion of starting material.
Again, the compound was not puriﬁed and immediately
cyclized by heating at reﬂux in methanol with DBU to give
amide 18 in 20% yield over three steps. Conditions were tested
for ﬂash vacuum pyrolysis of this material. The inlet
temperature was kept at 226 °C (the melting point of the
cycloadduct), and the pressure set at 1 × 10−2 mbar. The initial
temperature of the furnace was set at 560 °C, which initiated
the retro-Diels−Alder reaction but led to decomposition. A
similar observation was made when the temperature was
lowered to 520 °C (Table 2, entries 1 and 2). At a temperature
of 510 °C, a mixture of anthracene and starting material was
obtained alongside some decomposed material in the u-tube
collection vessel. Although some peaks of pyrrolam A were
observed in the crude 1H NMR spectrum, pure material was
not successfully isolated (Table 2, entry 3). The best result was
obtained when the furnace temperature was set at 490 °C
(Table 2, entry 4), which led to the isolation of pure desired
product 19 in 68% yield with no decomposition being
observed. The slight drop in the ee of product compared to
starting material (94 vs 99%) is probably due to the stability of
the product, as has been noted in previous isolation and
synthetic studies on this target.7,8a When the temperature was
further lowered to 470 °C, a retro-Diels−Alder failed to occur,
returning only the starting material, indicating the narrow
window of operation for conducting the FVP process.
A model for the stereoselectivity of this reaction can be
proposed using the same basis as previously noted.4b Thus,
preferential coordination of the Lewis acidic boron center of
the oxazaborolidine occurs to minimize steric interactions of
the B-Me group with the nitrogen substituent (the “large”
group using the traditional CBS model). This leads to two
possible intermediates, where only in one case can reduction
Scheme 5. Allyl Trimethylsilane Addition to Aminal 6
Scheme 6. Synthesis of Pyrrolam A
Table 2. Flash Vacuum Pyrolysis of Bicycle 18a
product distribution (%)b
entry furnace temp (°C) 18 anthracene pyrrolam 19
1 560 0 73 0
2 520 0 50 0
3 510 50 11 0
4 490 30 69 68
5 470 87 0 0
aInlet temperature of 226 °C at a pressure of 1 × 10−2 mbar. Reactions
performed over a period of 20−40 min until no further sublimation of
the starting material was observed. bRefers to yield of isolated material.
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then occur from the more sterically accessible face of the imide
(Figure 1).
In conclusion, an eﬃcient strategy has been developed to
eﬀect the highly enantioselective desymmetrization of mal-
eimide, with the discovery of an in situ stereoablative process
that serves to upgrade the observed enantioselectivity. Here we
have exempliﬁed the strategy in the synthesis of pyrrolam A,
paving the way for further functionalization of the intermediate
hydroxyaminals to provide access to more complex pyrrolidine
building blocks.
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